VeraBank N.A. lessened its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 22.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,197 shares of the pharmacy operator’s stock after selling 1,814 shares during the period. VeraBank N.A.’s holdings in CVS Health were worth $278,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also made changes to their positions in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC boosted its stake in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC bought a new position in CVS Health in the fourth quarter valued at about $28,000. Livelsberger Financial Advisory acquired a new position in CVS Health during the third quarter worth about $31,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Price Performance
CVS Health stock opened at $65.71 on Friday. The stock’s 50 day moving average price is $51.11 and its two-hundred day moving average price is $56.08. The stock has a market capitalization of $82.68 billion, a price-to-earnings ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75.
CVS Health Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.05%. CVS Health’s payout ratio is currently 67.51%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. Barclays increased their price objective on shares of CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday. Evercore ISI raised their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Leerink Partners raised CVS Health from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $55.00 to $75.00 in a report on Thursday. Royal Bank of Canada reduced their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, Piper Sandler dropped their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $70.28.
Check Out Our Latest Report on CVS
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- What is the S&P/TSX Index?
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Using the MarketBeat Stock Split Calculator
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.